Equities

IMD International Medical Devices SpA

IMD International Medical Devices SpA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)1.45
  • Today's Change-0.04 / -2.68%
  • Shares traded9.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 04 2024 16:35 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

IMD International Medical Devices SpA, also known as IMD Group, is an Italy-based holding company engaged in the design, development, manufacturing, and distribution of diagnostic systems. The Company operates through its subsidiaries and the activities of the IMD Group are divided into two business areas: X-Ray Generators (through the subsidiary IMD Generators) that develops, manufactures and distributes components for medical equipment such as monoblocs, generators and control systems; X-Ray Imaging Devices (through the subsidiaries Technix and Intermedical) that develops, manufactures and distributes the complete medical equipment based on X-ray technology for different health departments. IMD Group serves customers globally.

  • Revenue in EUR (TTM)38.01m
  • Net income in EUR2.22m
  • Incorporated1981
  • Employees116.00
  • Location
    IMD International Medical Devices SpAVia Enrico Fermi, 26GRASSOBBIO 24050ItalyITA
  • Websitehttps://www.imdgroup.it/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Episurf Medical AB968.80k-8.11m17.91m25.00--1.42--18.49-0.266-0.2660.03180.18610.0852--5.24392,857.20-71.42-47.46-81.48-52.01-----838.18-1,019.292.54--0.068--53.6219.78-22.64---0.4158--
Arcoma AB15.14m828.06k18.00m31.0021.743.8712.391.190.7130.71313.044.011.813.716.935,544,871.009.921.1218.492.0136.8337.665.470.75680.978811.950.04750.0030.366.4134.81--22.75--
Nexstim Oyj7.25m-1.33m18.81m37.00--6.63--2.60-0.1956-0.19561.090.41920.72110.27083.76195,845.70-13.21-26.77-20.24-43.9096.3892.11-18.32-38.381.42-12.600.61---23.9422.08-201.58--19.51--
Diagnostic Medical Systems SA42.15m-9.76m18.91m147.00--1.49--0.4487-0.4982-0.24812.230.70230.80271.816.81286,755.10-18.73-12.33-33.53-22.1437.5837.72-23.33-16.450.7105-3.520.5938--19.5111.62-106.30------
Alpha Mos SA4.51m-4.74m19.95m53.00------4.43-0.4345-0.43450.4127-0.74280.5992.937.3685,000.00-63.06-47.80-521.78-139.0945.5568.00-105.28-68.640.2498-6.78-----22.464.97-76.91------
SpectraCure AB (publ)233.39k-1.85m21.77m13.00--2.00--93.28-0.2168-0.21680.02731.280.0178--19.00176,666.70-14.11-12.75-15.44-13.62393.13195.30-794.75-494.40----0.0499---3.30--19.46------
Geratherm Medical AG25.03m1.04m22.32m188.0013.630.97436.710.8920.30080.30085.434.210.63521.077.37119,744.404.362.535.363.0866.2065.826.863.523.5437.640.2596164.987.984.21737.258.5312.77-20.42
Ondine Biomedical Inc543.97k-12.65m22.87m43.00--5.73--42.04-0.0554-0.05540.00240.01230.04920.35845.5410,771.68-114.33---135.98--49.00---2,326.12--1.93--0.1961---75.17--61.32------
Seyitler Kimya Sanayi AS4.03m1.06m23.51m63.0022.245.0620.695.830.37090.37091.411.630.7141.737.011,836,392.0018.7336.2022.3544.0238.1239.8626.2343.893.38--0.13190.0084.4045.46193.51107.1230.39--
IMD International Medical Devices SpA38.01m2.22m25.41m116.0011.221.168.240.66860.12840.12842.191.24------327,653.90--------27.27--6.45--1.59--0.0638---9.07---24.35------
Belluscura PLC1.11m-9.22m25.66m24.00--0.908--23.15-0.0634-0.06340.00760.14580.04450.21970.309939,333.23-36.98-35.98-40.59-39.17-32.24-40.01-831.69-838.024.17-3.430.00--232.6231.09-56.38--30.90--
Scandinavian Medical Solutions A/S26.48m720.23k26.11m25.0036.062.5216.070.98580.19630.19637.222.811.381.8911.35--3.75--6.15--24.48--2.72--0.43075.540.3473--72.98--7.49------
Mauna Kea Technologies SA10.48m-3.73m26.18m68.00------2.50-0.0578-0.05780.2126-0.28090.49052.312.45154,117.60-17.45-51.23-223.84-93.3033.6211.15-35.57-142.410.42874.292.38--40.139.1666.66---21.16--
Acarix AB514.26k-6.72m26.53m9.00--2.89--51.58-0.1431-0.14310.01030.10690.08210.12573.51---107.29-66.93-125.57-77.1286.0479.42-1,306.54-1,483.686.88-312.950.00--7.2043.55-1.11------
Biocartis Group NV60.61m-67.87m27.24m526.00------0.4493-0.9993-0.99930.8171-0.57480.55481.563.31115,231.90-62.13-34.35-84.71-40.3851.4040.84-111.97-145.711.60-2.551.55--19.0822.368.52---14.81--
Micropos Medical AB (publ)156.06k-2.09m31.31m9.00--13.83--200.63-0.258-0.2580.01490.16920.05290.09990.7758221,497.50-70.97-64.24-89.99-82.2774.48114.76-1,340.85-767.574.04--0.0146--50.235.94-26.57------
Data as of Jun 04 2024. Currency figures normalised to IMD International Medical Devices SpA's reporting currency: Euro EUR

Institutional shareholders

1.70%Per cent of shares held by top holders
HolderShares% Held
Sella SGR SpAas of 30 Apr 2024150.75k0.85%
GVC Gaesco Gesti�n SGIIC SAas of 31 Mar 202488.88k0.50%
Azimut Capital Management SGR SpAas of 30 Apr 202460.75k0.34%
Data from 31 Mar 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.